Naturhouse Health (2NH) Financial Statements
Naturhouse Health Financial Overview
Naturhouse Health's market cap is currently $136.09M. The company's EPS TTM is $0.15; its P/E ratio is 15.63; and it has a dividend yield of 13.27%. Naturhouse Health is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 47.63M | $ 49.42M | $ 50.41M | $ 52.40M | $ 57.59M |
| Gross Profit | $ 12.94M | $ 35.46M | $ 25.11M | $ 37.48M | $ 41.26M |
| Operating Income | $ 13.31M | $ 13.15M | $ 16.26M | $ 12.85M | $ 17.34M |
| EBITDA | $ 14.45M | $ 15.63M | $ 17.93M | $ 15.61M | $ 20.80M |
| Net Income | $ 10.09M | $ 9.86M | $ 11.29M | $ 9.63M | $ 13.36M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 14.57M | $ 21.67M | $ 27.10M | $ 14.78M | $ 27.25M |
| Total Assets | $ 33.43M | $ 42.59M | $ 48.85M | $ 42.82M | $ 49.00M |
| Total Debt | $ 3.43M | $ 4.27M | $ 5.05M | $ 5.38M | $ 4.37M |
| Net Debt | $ -10.00M | $ -16.41M | $ -19.33M | $ -6.73M | $ -22.88M |
| Total Liabilities | $ 15.68M | $ 10.91M | $ 18.21M | $ 14.96M | $ 12.92M |
| Stockholders' Equity | $ 17.75M | $ 31.68M | $ 30.63M | $ 27.81M | $ 36.02M |
| Cash Flow | |||||
| Free Cash Flow | $ 11.67M | $ 11.22M | $ 20.38M | $ 6.13M | $ 16.12M |
| Operating Cash Flow | $ 12.15M | $ 11.56M | $ 20.95M | $ 7.10M | $ 16.17M |
| Investing Cash Flow | $ -420.00K | $ 862.00K | $ -459.00K | $ -5.22M | $ -4.27M |
| Financing Cash Flow | $ -18.95M | $ -16.10M | $ -7.70M | $ -16.98M | $ -6.27M |
Currency in EUR